262 related articles for article (PubMed ID: 12287845)
1. Contraception and cancer prevention.
Ursin G; Spicer DV; Pike MC
Adv Contracept Deliv Syst; 1994; 10(3-4):369-86. PubMed ID: 12287845
[TBL] [Abstract][Full Text] [Related]
2. Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer.
Spicer DV; Pike MC; Pike A; Rude R; Shoupe D; Richardson J
Contraception; 1993 May; 47(5):427-44. PubMed ID: 8390340
[TBL] [Abstract][Full Text] [Related]
3. [Oral contraception and its beneficial gynecological effects].
Belaisch J; Hommais-loufrani B
Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
[TBL] [Abstract][Full Text] [Related]
4. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
5. Researchers can now investigate long-term effects of OCs on cancer.
Rubin GL; Peterson HB
Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
[TBL] [Abstract][Full Text] [Related]
6. The pill and the breast.
Drife JO
IPPF Med Bull; 1984 Dec; 18(6):1-2. PubMed ID: 12313402
[TBL] [Abstract][Full Text] [Related]
7. [Pros and cons of triphasic oral contraception].
Berdah J
Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1205-10. PubMed ID: 12267512
[TBL] [Abstract][Full Text] [Related]
8. [The present state of research on the relationship of oral contraceptives to breast cancer].
Pike MC
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
[TBL] [Abstract][Full Text] [Related]
9. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
[TBL] [Abstract][Full Text] [Related]
10. Contraception and the big "C".
Chandran R
Malays J Reprod Health; 1992 Jun; 10(1):1-5. PubMed ID: 12345024
[TBL] [Abstract][Full Text] [Related]
11. [Disease and contraception. Recent aspects].
Rozenbaum H
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):431-6. PubMed ID: 12280211
[TBL] [Abstract][Full Text] [Related]
12. Researcher explains status of Depo Provera. [Answer to question of Marienetta Blackwell].
Greenspan A
Contracept Technol Update; 1981 Mar; 2(3):35-6. PubMed ID: 12337540
[TBL] [Abstract][Full Text] [Related]
13. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
London RS
J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
[TBL] [Abstract][Full Text] [Related]
14. [Oral contraception: failures and risks].
Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
[TBL] [Abstract][Full Text] [Related]
15. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
[TBL] [Abstract][Full Text] [Related]
16. Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study).
Pelissier C; Basdevant A; Conard J; Egloff M; Husson T; Guyenne TT
Contracept Fertil Sex (Paris); 1987 Jan; 15(1):45-54. PubMed ID: 12315161
[TBL] [Abstract][Full Text] [Related]
17. [Macroprogestative contraception: advantages].
Jamin C
Contracept Fertil Sex (Paris); 1993 Feb; 21(2):123-8. PubMed ID: 12318009
[TBL] [Abstract][Full Text] [Related]
18. Hormonal contraception.
Baird DT; Glasier AF
N Engl J Med; 1993 May; 328(21):1543-9. PubMed ID: 8479492
[TBL] [Abstract][Full Text] [Related]
19. Estrogen, progesterone dosage varies in new oral contraceptive.
Contracept Technol Update; 1984 Mar; 5(3):35-6. PubMed ID: 12312849
[TBL] [Abstract][Full Text] [Related]
20. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
Le Coutour X
NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]